Dr. Andrei H. Iagaru, MD
Nuclear Medicine (Nuclear Radiology Physician)
300 Pasteur Dr
Stanford, CA 94305
Who else practices at this address →
Santa Clara County includes mental health (13% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 26
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 898
Licensed in California since 2005, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Nuclear Radiology Physician primary
CA license A92375 (first issued 2005; current) -
Nuclear Medicine Physician
CA license A92375 (first issued 2005; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Stanford Health Care Stanford, CA
- Stanford Health Care Tri-Valley Pleasanton, CA
Medical groups
- Stanford Health Care (3,122 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 898
- Services billed
- 967
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Dxa bone density measurement of hip, pelvis, spine | 469 | 469 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 266 | 259 |
| Nuclear medicine study whole body with ct scan | 109 | 105 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 88 | 88 |
| Nuclear medicine study, spect imaging with concurrent ct scan, 1 area or single acquisition, single day imaging | 68 | 66 |
| Nuclear medicine study of bone and/or joint whole body | 33 | 31 |
| Calculation of radiation therapy dose | 31 | 29 |
| Radioactive drug therapy through a vein | 28 | 25 |
| Nuclear medicine study of stomach to assess emptying | 17 | 17 |
| Nuclear medicine study of lymphatic system | 16 | 16 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 5 companies reported 17 payments worth $44,138 in total to this clinician.
| Lantheus Medical Imaging, Inc. | $27,136 |
|---|---|
| GE Healthcare | $10,782 |
| Genzyme Corporation | $3,197 |
| Novartis Pharmaceuticals Corporation | $2,810 |
| Progenics Pharmaceuticals, Inc. | $214 |
| Consulting Fee | $25,545 |
|---|---|
| Travel and Lodging | $17,834 |
| Food and Beverage | $759 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| GE Healthcare Aug 22, 2025 | Travel and Lodging travel to Belo Horizonte / S?o Paulo, Brazil · in-kind | $9,540 |
| Lantheus Medical Imaging, Inc. Nov 6, 2025 | Consulting Fee | $7,950 |
| Lantheus Medical Imaging, Inc. Nov 25, 2025 | Consulting Fee | $7,950 |
| Lantheus Medical Imaging, Inc. Nov 18, 2025 | Travel and Lodging travel to NEWARK, NJ · in-kind | $7,261 |
| Lantheus Medical Imaging, Inc. Nov 18, 2025 | Consulting Fee | $3,975 |
| Genzyme Corporation Jan 22, 2025 | Consulting Fee | $2,970 |
| Novartis Pharmaceuticals Corporation Feb 14, 2025 | Consulting Fee | $2,700 |
| GE Healthcare Aug 22, 2025 | Travel and Lodging travel to Belo Horizonte / S?o Paulo, Brazil · in-kind | $682 |
| GE Healthcare Jun 24, 2025 | Travel and Lodging travel to New Orleans, LA · in-kind | $239 |
| Genzyme Corporation Jan 22, 2025 | Travel and Lodging travel to San Francisco, CA | $112 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $27,840 in research payments for these studies, mostly to the institutions running them.
- A Phase 1 First-in-human Multicentre Open-label Dose escalation Study of 225Ac-FPI-2068 in Adult Patients with Advanced Solid Tumours
AstraZeneca Pharmaceuticals LP - An Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care, Versus Standard of Care Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
Novartis Pharmaceuticals Corporation
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.